Rezolute (RZLT) Times Interest Earned (2012 - 2026)
Rezolute (RZLT) posted Times Interest Earned of -$5.11 for Q1 2026, up 47.28% sequentially from -$9.69 in Q4 2025, and down 7.14% YoY from -$5.5 in Q1 2025.
Rezolute (RZLT) Times Interest Earned (2012 - 2026) Analysis & Trends
Rezolute has reported Times Interest Earned for 15 years, with the latest figure at -$5.11 in Q1 2026.
- Quarterly Times Interest Earned fell 7.14% year-over-year to -$5.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.66 (down 39.71% YoY) and the FY2025 annual result came in at -$0.89, up 81.58% from the prior year.
- Times Interest Earned rose to -$5.11 in Q1 2026 per RZLT's latest filing, from -$9.69 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.27 in Q3 2025 and troughed at -$136.77 in Q2 2025.
- A 5-year average of -$35.16 and a median of -$15.36 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned soared 97.97% in 2024, then plunged 989.09% in 2025.
- Over 5 years, Times Interest Earned stood at -$24.07 in 2022, then sank by 82.46% to -$43.91 in 2023, then jumped by 97.97% to -$0.89 in 2024, then slumped by 989.09% to -$9.69 in 2025, then jumped by 47.28% to -$5.11 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$5.11, -$9.69, and -$0.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | -5.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.11 |
| Dec 31, 2025 | -9.69 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -136.77 |
| Mar 31, 2025 | -4.77 |
| Dec 31, 2024 | -0.89 |
| Sep 30, 2024 | -0.88 |
| Jun 30, 2024 | -125.55 |
| Mar 31, 2024 | -4.50 |
| Dec 31, 2023 | -43.91 |
| Sep 30, 2023 | -23.89 |
| Jun 30, 2023 | -111.23 |
| Mar 31, 2023 | -5.85 |
| Dec 31, 2022 | -24.07 |
| Sep 30, 2022 | -61.19 |
| Jun 30, 2022 | -23.74 |
| Mar 31, 2022 | -15.36 |
| Dec 31, 2021 | -17.36 |
| Sep 30, 2021 | -10.91 |
| Jun 30, 2021 | -276.50 |